Two Sigma Securities’s 60 Degrees Pharmaceuticals Warrant SXTPW Stock Holding History

Two Sigma Securities’s Portfolio SXTPW Stock Details SXTPW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$1.14K	Sell	22,693 -2,080	-8%	-$134	﹤0.01%	1570
2025 Q4	$1.56K	Buy	24,773 +11,187	+82%	+$547	﹤0.01%	1378
2025 Q3	$503	Buy	+13,586	New	+$932	﹤0.01%	1304

Other funds holding SXTPW

Walleye Capital New York $24B AUM 37.67% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Torno Capital Cohasset, Massachusetts $725M AUM 62.71% 1-Year Est. Return

Mariner Overland Park, Kansas $85.7B AUM 24.21% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Two Sigma Securities's SXTPW Position: Q1 2026 in Review

Two Sigma Securities reduced its 60 Degrees Pharmaceuticals Warrant (SXTPW) stake by 8.4% in Q1 2026, selling an estimated $134 and leaving 22,693 shares worth $1.14K. The position accounts for ﹤0.01% of the portfolio, ranked #1570.

Two Sigma Securities first reported a position in SXTPW in Q3 2025 and has held it in 3 quarters since. The position peaked at $1.56K in Q4 2025. 8 funds tracked by Wall St. Rank hold SXTPW as of Q1 2026.

Two Sigma Securities held 22,693 shares of 60 Degrees Pharmaceuticals Warrant worth $1.14K as of Q1 2026.
Two Sigma Securities sold 2,080 60 Degrees Pharmaceuticals Warrant shares in Q1 2026, an estimated $134.
60 Degrees Pharmaceuticals Warrant made up ﹤0.01% of Two Sigma Securities's portfolio in Q1 2026, its #1570 holding.
Two Sigma Securities first reported a position in 60 Degrees Pharmaceuticals Warrant in Q3 2025 and has held it in 3 quarters since.
Two Sigma Securities's 60 Degrees Pharmaceuticals Warrant position peaked at $1.56K in Q4 2025.
8 funds tracked by Wall St. Rank held 60 Degrees Pharmaceuticals Warrant as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.